Differences

This shows you the differences between two versions of the page.

--- marcie_glicksman [2022/12/06 15:24]
pamela created
+++ marcie_glicksman [2022/12/06 16:11] (current)
pamela [Therapeutic Drug Development Crossing Blood Brain Barrier]
@@ Line 1: / Line 1: @@
 ===== Marcie Glicksman =====
-Dr. Marcie Glicksman received her Bachelor’s degree from Brown University in Providence, Rhode Island and her Ph.D. in neuroscience from [[:Washington University in St. Louis]], Missouri. (known for **Monsanto**'s global HQ & academic partner )
+==== Official Bio 2022 ====
+{{ ::marcie_glicksman_-_orig3n_-_harvard.png?200|}}
+Dr. Marcie Glicksman received her Bachelor’s degree from Brown University in Providence, Rhode Island and her Ph.D. in neuroscience from [[:Washington University]] in St. Louis, Missouri.
+(WU is known for **Monsanto**'s global HQ & academic partners eg Danforth Center)
-Dr. Glicksman has been in the field of drug discovery for 18 years, the most recent five in academics and thirteen years in the pharmaceutical/biotech industry, having worked at [[:Cephalon]], [[:DuPont]]-[[:Merck]], [[:Cubist]] (as director of leads discovery), and the start up company, [[:Descartes Therapeutics]].
+Dr. Glicksman has been in the field of drug discovery for 18 years, the most recent five in academics and thirteen years in the pharmaceutical/biotech industry, having worked at [[:Cephalon]], [[:DuPont]] - [[:Merck]], [[:Cubist]] (as director of leads discovery), and the start up company, [[:Descartes Therapeutics]].
 She is currently the senior director of the leads discovery group at the Laboratory for Drug Discovery in Neurodegeneration, which is part of the [[:Harvard NeuroDiscovery Center]], and assistant professor in the Neurology Department at [[:Brigham and Women’s Hospital]] and [[:Harvard Medical School]].
@@ Line 10: / Line 13: @@
 She has extensive experience in **assay development, high throughput screening, and chemical databases** as well as animal [[:pharmacology]] and preclinical development. ((https://web.archive.org/web/20221206141139/https://www.science.org/content/author/marcie-glicksman-phd))
+==== Therapeutic Drug Development Crossing Blood Brain Barrier ====
+The EnClear Team | www. encleartherapies.com/copy-of-the-enclear-team
+Head of Biology Marcie Glicksman, PhD For the past 30 years, Dr. Glicksman has been dedicated to developing better therapeutics for the nervous system and other therapeutic areas. Her efforts have resulted in 8 drugs entering the clinic, **2 marketed drugs** resulting in over **$2B in sales** for [[:Cephalon]] (now Teva Pharmaceuticals) and [[:Cubist]] (now Merck). ((https://web.archive.org/web/20220524183432/https://www.encleartherapies.com/programs-copy))
+Our strategy is two-fold: 1) Lead with neuro-[[:oncology]] and help patients with Leptomeningeal Carcinomatosis.
+) Leveraging partnerships to expand into **neurodegenerative, lysosomal storage & autoimmune diseases**.
+Therapeutics targeting CNS disorders are ineffective at reaching critical areas of the CNS through traditional means to be efficacious.
+Difficulty delivering past the [[:Blood Brain Barrier]], Blood-CSF, and Blood Arachnoid barriers.
+Difficulty delivering to localized areas in the CNS
+Increased dosing required to get to efficacious levels
+Higher risk of peripheral toxicity and severe side effects
+With EnClear's CSF Health Platform, therapeutics can be moved from specialized hospitals to local **infusion clinics**.((https://web.archive.org/web/20220524183621/https://www.encleartherapies.com/csf-health-platform))
+==== Orig3n VP of Biology ====
+(Unnamed in Science-org bio)
+Dr. Marcie Glicksman has been in the drug discovery field for over 20 years, and has extensive experience in assay development, high throughput screening, and chemical databases. Before joining ORIG3N, she was Co-Director of the Laboratory for Drug Discovery in Neurodegeneration (LDDN), part of the Harvard NeuroDiscovery Center. She holds a BA from Brown University and a PhD in Neuroscience from Washington University.((https://web.archive.org/web/20151025003932/http://www.orig3n.com/team/))